Trial Profile
Category 3 abuse-deterrent study of the abuse-deterrent, extended-release oxycocone product Egalet 002
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Jul 2019
Price :
$35
*
At a glance
- Drugs Oxycodone (Primary)
- Indications Pain
- Focus Adverse reactions
- 16 Dec 2016 According to an Egalet media release, full data from this trial will be presented at a medical meeting in 2017.
- 16 Dec 2016 Results published in an Egalet Media Release
- 25 Aug 2016 According to an Egalet media release, the data of this trial would be presented PAINWeek 2016.